RC
SNY icon

Rexford Capital’s Sanofi SNY Stock Holding History

Rexford Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495K Buy
10,276
+68
+0.7% +$3.17K 0.35% 82
2025
Q4 		$495K Hold
10,208
– – 0.37% 83
2025
Q3 		$482K Hold
10,208
– – 0.37% 87
2025
Q2 		$493K Buy
+10,208
New +$522K 0.41% 76

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rexford Capital's SNY Position: Q1 2026 in Review

Rexford Capital increased its Sanofi (SNY) stake by 0.67% in Q1 2026, buying an estimated $3.17K and bringing the position to 10,276 shares worth $495K. The position accounts for 0.35% of the portfolio, ranked #82.

Rexford Capital first reported a position in SNY in Q2 2025 and has held it in 4 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Rexford Capital held 10,276 shares of Sanofi worth $495K as of Q1 2026.
  • Rexford Capital bought 68 Sanofi shares in Q1 2026, an estimated $3.17K.
  • Sanofi made up 0.35% of Rexford Capital's portfolio in Q1 2026, its #82 holding.
  • Rexford Capital first reported a position in Sanofi in Q2 2025 and has held it in 4 quarters since.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.